(FGEN) FibroGen - Performance -74.8% in 12m
Compare FGEN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-84.09%
#150 in Group
Rel. Strength
5.35%
#7531 in Universe
Total Return 12m
-74.75%
#143 in Group
Total Return 5y
-99.22%
#183 in Group
P/E -
(?) Percentile in Group
P/E Forward 61.4
88th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: FGEN (-74.8%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: FGEN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for FGEN
Total Return (including Dividends) | FGEN | XBI | S&P 500 |
---|---|---|---|
1 Month | 17.15% | 2.02% | 2.87% |
3 Months | -38.19% | -15.44% | -6.42% |
12 Months | -74.75% | -14.02% | 9.87% |
5 Years | -99.22% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | FGEN | XBI | S&P 500 |
1 Month | 67.1% | 57% | 89.4% |
3 Months | -78.8% | -82.3% | -72% |
12 Months | -62.2% | -53.1% | 49.3% |
5 Years | -87.5% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #87 | 14.8% | 13.9% |
3 Month | #143 | -26.9% | -34.0% |
12 Month | #145 | -70.6% | -77.0% |
5 Years | #184 | -98.9% | -99.6% |
FAQs
Does FGEN FibroGen outperforms the market?
No,
over the last 12 months FGEN made -74.75%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months FGEN made -38.19%, while XBI made -15.44%.
Over the last 3 months FGEN made -38.19%, while XBI made -15.44%.
Performance Comparison FGEN vs Indeces and Sectors
FGEN vs. Indices FGEN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.19% | 14.3% | -3.89% | -84.6% |
US NASDAQ 100 | QQQ | -7.44% | 12.4% | -4.30% | -86.1% |
US Dow Jones Industrial 30 | DIA | -7.47% | 15.5% | -2.86% | -81.1% |
German DAX 40 | DAX | -9.31% | -2.13% | -29.5% | -99.8% |
Shanghai Shenzhen CSI 300 | CSI 300 | -7.85% | 10.9% | -3.12% | -80.4% |
Hongkong Hang Seng | HSI | -10.7% | 0.94% | -13.4% | -86.8% |
India NIFTY 50 | INDA | -4.80% | 14.9% | -5.79% | -77.1% |
Brasil Bovespa | EWZ | -9.24% | 5.62% | -13.1% | -68.3% |
FGEN vs. Sectors FGEN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -7.37% | 13.5% | -10.1% | -95.1% |
Consumer Discretionary | XLY | -8.11% | 13.6% | -1.70% | -88.8% |
Consumer Staples | XLP | -6.82% | 15.1% | -10.8% | -82.3% |
Energy | XLE | -8.17% | 17.1% | 2.11% | -65.0% |
Financial | XLF | -7.82% | 11.6% | -9.77% | -96.3% |
Health Care | XLV | -3.40% | 21.5% | 1.34% | -68.8% |
Industrial | XLI | -8.76% | 9.77% | -4.87% | -84.7% |
Materials | XLB | -7.18% | 12.4% | 0.16% | -68.7% |
Real Estate | XLRE | -6.86% | 11.0% | -6.27% | -88.2% |
Technology | XLK | -8.08% | 10.4% | -1.62% | -81.8% |
Utilities | XLU | -8.23% | 11.5% | -11.7% | -90.7% |
Aerospace & Defense | XAR | -7.70% | 7.81% | -13.2% | -99.9% |
Biotech | XBI | 0.89% | 15.1% | 17.2% | -60.7% |
Homebuilder | XHB | -6.75% | 14.1% | 9.74% | -65.0% |
Retail | XRT | -7.34% | 13.6% | 2.40% | -70.4% |